key: cord-0824873-lgvorn2v
authors: D’Antonio, Matteo; Nguyen, Jennifer P.; Arthur, Timothy D.; Matsui, Hiroko; D’Antonio-Chronowska, Agnieszka; Frazer, Kelly A.
title: SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a wide variety of tissues
date: 2021-11-03
journal: Cell Rep
DOI: 10.1016/j.celrep.2021.110020
sha: d1a4a2b216c6a2099aff442cabe2e270d228ac57
doc_id: 824873
cord_uid: lgvorn2v

Variability in SARS-CoV-2 susceptibility and COVID-19 disease severity between individuals is partly due to genetic factors. Here, we identify four genomic loci with suggestive associations for SARS-CoV-2 susceptibility and nineteen for COVID-19 disease severity. Four of these 23 loci likely have an ethnicity-specific component. GWAS signals in eleven loci colocalize with eQTLs associated with the expression of 20 genes in 62 tissues/cell types (range: 1:43 tissues/gene) including lung, brain, heart, muscle, skin as well as the digestive system and immune system. We perform genetic fine mapping to compute 99% credible SNP sets, which identify ten GWAS loci that have eight or fewer SNPs in the credible set, including three loci with one single likely causal SNP. Our study suggests that the diverse symptoms and disease severity of COVID-19 observed between individuals is associated with variants across the genome affecting gene expression levels in a wide variety of tissue types.

Variability in SARS-CoV-2 susceptibility and COVID-19 disease severity between individuals is partly due to genetic 23 factors. Here, we identify four genomic loci with suggestive associations for SARS-CoV-2 susceptibility and nineteen for 24 COVID-19 disease severity. Four of these 23 loci likely have an ethnicity-specific component. GWAS signals in eleven 25 loci colocalize with eQTLs associated with the expression of 20 genes in 62 tissues/cell types (range: 1:43 tissues/gene) 26 including lung, brain, heart, muscle, skin as well as the digestive system and immune system. We perform genetic fine 27 mapping to compute 99% credible SNP sets, which identify ten GWAS loci that have eight or fewer SNPs in the credible 28 set, including three loci with one single likely causal SNP. Our study suggests that the diverse symptoms and disease 29 Introduction and TYK2), macrophages (immune response: IFNAR2), neutrophils (immune response: IL10RB), B-cells (immune 134 response: IFNAR2), LCL (immune response: ARL17B, LRRC37A and IFNAR2), monocytes (immune response: ABO, 135 IL10RB, LRRC37A, LRRC37A2, OAS1 and TYK2), T-cells (immune response: IFNAR2), skeletal muscle (muscle fatigue  136   and body aches: ABO, IFNAR2, IL10RB, IL10RB-AS1, LRRC37A, LRRC37A2 and TCF19) , digestive system (nausea and 137 diarrhea: ABO, LRRC37A, PTPRS, AP000295.10, IL10RB, IFNAR2 and NXPE3), brain cortex (loss of smell and taste, 138 cognitive defects: LRRC37A and LRRC37A2, Table S2 ), heart (myocarditis, cardiomyopathy and heart failure: ABO, 139 FAM198B, LRRC37A and PDCL3P4) and skin (skin rashes: LRRC37A, OAS1 and TYK2). Surprisingly, five of the eleven 140 (44.4%) GWAS signals did not colocalize with eQTLs in blood or lung, the two tissues that have been described as the 141 most affected by To identify putative causal variants, we performed genetic fine mapping (Mahajan et al., 2018) in each of the 11 loci using 143 the colocalization results between the GWAS signal and the gene with the best colocalizing eQTL signal (i.e. highest PP-144 H4). We calculated the posterior probability of each SNP tested both in the GWAS and eQTL analysis to be causal 145 (posterior probability of association, PPA). We next combined all the SNPs with the highest PPAs to compute 99% 146 credible sets, defined as the SNPs whose sum of PPA is >99% ( Figure 4 , Table S3, Table S4 ). For ten GWAS loci, we 147 were able to determine 99% credible sets that included eight or fewer SNPs, including three with one single likely causal 148 SNP. For the remaining GWAS locus, the 99% credible set included 57 SNPs, the most likely causal SNP had PPA = 149 0.58. 150

Genetic fine mapped GWAS signals 151 Here, we report a description of each of the 11 fine mapped GWAS signals. 152 6:40997035-42005196 and lung-specific eQTL for FOXP4. The 6:40997035-42005196 locus was associated with 153 COVID-19 disease severity in multi-ethnic meta-analyses, but not with European-only meta-analyses (Figure 1, Figure  154 2G-I). Interestingly, the lead GWAS variant in this locus (rs1886814) is less common in Europeans (gnomAD allele 155 frequency = 2.4%) than in East Asians (37.3%), Admixed Americans (18.9%), or South Asians (11.8%) (Karczewski et 156 al., 2020) and was found to be associated with COVID-19 in East Asians by the COVID-19 HGI (Initiative, 2020 (Initiative, , 2021 . major histocompatibility complex (MHC). The GWAS signal in this locus was associated with COVID-19 disease 167 severity and colocalized with a cerebellum-specific eQTL for HLA-DPA2 ( Figure 4B ), a member of the MHC class II 168 with unknown function (Jones et al., 2006; Roche and Furuta, 2015 Figure 4C ), which encodes a phosphatase with three immunoglobulin-like domains whose knockdown 179 results in ulcerative colitis in mice (Muise et al., 2007) . The eQTL is 481 kb downstream of PTPRS (which is transcribed 180 on the reverse strand) and hence likely in a distal regulatory element. Interestingly, the protein product of PTPRS was 181 shown to interact with the membrane (M) protein of SARS-CoV-2 (Estelle M.N. Laurent et al., 2020; Payman 182

Samavarchi-Tehrani et al., 2020), which likely glycosylates the spike protein (Thomas, 2020) . These data suggest that 183 increased expression of PTPRS in the sigmoid colon is causally associated with COVID-19 disease severity. 184 1:154605882-155673527 and atrial appendage-specific eQTL for FAM189B. In the 1:154605882-155673527 locus, the 185 GWAS signal colocalized with an eQTL for FAM189B in cardiac tissues (atrial appendage, effect size β = -0.23, Figure  186 4D, Table S3 ). Although this gene's function has not been well-characterized, it has been shown that rare coding variants 187 in its sequence are associated with increased triglyceride levels in the blood (Gilly et al., 2018). Of note, high triglyceride 188 levels prior to infection serve as a prognostic marker for severe COVID-19 outcomes 189 Wang et al., 2020; Wei et al., 2020) . Recent evidence showed that the FAM189B protein product can bind to the SARS- we were not able to identify one single likely causal variant, but fine mapping was able to reduce the number of 202 potentially causal variants to four. Our results suggest that increased expression of TCF19 in multiple tissues maybe 203 associated with COVID-19 disease severity potentially due to alterations in the immune response regulating inflammation. 204 19:9927721-10977067 and TYK2. The 19:9927721-10977067 locus disease severity-associated GWAS signal colocalized 205 with eQTLs for TYK2 in seven tissues, including adrenal gland, tibial artery, breast, lung, monocytes, skin and whole 206 blood (effect size β = 0.45, Figure 4F , Table S3 ). TYK2 encodes for a tyrosine kinase involved in the immune response, 207 whose inhibition has been described as a potential treatment for multiple autoimmune diseases (Ghoreschi et al., 2021) . OAS3 is unresolved because we found 59 variants in the 99% credible set, and the variant with the highest likelihood of 231 causality (rs6489879) had a PPA = 0.051. Our data suggest that decreased expression levels of OAS1 are likely causally 232 implicated in COVID-19 disease severity and are in agreement with previous studies showing that high plasma OAS1 3:100646362-102035347 and PDCL3P4, CEP97 and NXPE3. The GWAS signal for SARS-CoV-2 susceptibility in locus 235 3:100646362-102035347 colocalized with an eQTL signal of three genes in six distinct tissues (PDCL3P4: cerebellum, 236 hippocampus, nucleus accumbens basal ganglia and atrial appendage; CEP97: testis; and NXPE3: esophagus muscularis, 237 (effect size β = 0.74 for PDCL3P4 in cerebellum, Figure 4J , Table S3 ). Although we observed large 99% credible sets for 238 each of these three genes (57, 73 and 28, respectively), the lead variant for PDCL3P4 (rs10936744) had a moderately high 239 PPA (PPA = 0.579). The lead variants for the other two genes were in high LD with rs10936744 (rs34457525 for CEP97 240 and rs11714278 for NXPE3, R 2 > 0.97), suggesting that a single eQTL signal likely affects the expression of all three 241 genes. Although we were able to determine associations between the GWAS and eQTL signals in the 3:100646362-242 102035347 locus, further experiments will be needed to understand how increased expression of one or more of the genes 243 in this interval is implicated in SARS-CoV-2 susceptibility. analyses suggest that increased expression of one of the four genes in this locus is associated with COVID-19 disease 271 severity, the interval is genetically complex and the association could be due to molecular mechanisms that we did not 272 assay. 273

The COVID-19 pandemic has united the focus of the broad biomedical scientific community to improve our 275 understanding of the mechanisms underlying disease susceptibility and severity. The COVID-19 HGI has collected 276 genetic and COVID-19 status information from ~2 million individuals across 46 studies (Initiative, 2020 (Initiative, , 2021 , making 277 COVID-19 one of the best-powered GWAS studies ever conducted. Standard approaches to characterize GWAS summary 278 statistics focus on obtaining all the genomic loci where variants have p-value < 5 x 10 -8 and identifying the most likely 279 causal gene by proximity to the lead variant. Here, we compared 16 meta-analyses for four COVID-19 disease phenotypes 280 to investigate the similarities and differences in their genetic signals. We identified four genomic loci with suggestive 281 associations for SARS-CoV-2 susceptibility and nineteen for COVID-19 disease severity. Loci where the European-only 282 or the multi-ethnic meta-analyses, but not both, had p-values < 1 x 10 -7 , were labeled as "ethnicity-specific". Using these 283 annotations, we were able to confirm the findings by the COVID-19 HGI at multiple loci and to discover novel 284 associations at previously uncharacterized loci. Overall, our analyses showed that different intervals in the genome are 285 associated with SARS-CoV-2 susceptibility and COVID-19 disease severity, and that the genetic associations within four 286 of these intervals are likely ethnicity-specific. We next applied a colocalization method (Giambartolomei et al., 2014) to 287 compare the COVID-19 GWAS and eQTLs signals in the same intervals, based on the assumption that the molecular 288 underpinning of genetic variants associated with disease could be that they alter the expression of specific genes. GTEx 289 and the eQTL Catalogue (Consortium, 2020; Kerimov et al., 2021) provided us with the unique opportunity to investigate 290 the associations between genotype, gene expression and COVID-19 in 48 tissues and 21 blood-related cell types. While 291 the association between COVID-19 and altered gene expression in blood or lung may seem obvious, this disease affects 292 many other tissues and organs, suggesting that associations between genetic variation and gene expression in a wide 293 variety of tissues may result in differential disease susceptibility and severity. Our colocalization analysis identified 11 294 GWAS loci whose causal variants overlapped regulatory and coding variants associated with the expression of 20 genes, 295 of which some showed tissue-specific associations and others showed associations across many different tissue types. By 296 exploiting the colocalization between GWAS and eQTL signals, we were able to perform genetic fine mapping (Mahajan 297 et al., 2018) at all 11 COVID-19 loci and prioritize variants based on their likelihood for being causal. 298

In summary, our study examines the associations between COVID-19 disease phenotypes, genetic variation, and gene 299 expression in 48 human tissues and 21 blood-derived cell types and provides novel insights into the molecular 300 mechanisms underlying inherited predispositions to SARS-CoV-2 infection and COVID-19 disease severity. While 301 previous studies have mostly focused on associations between COVID-19 and lung or immune cell types, here we 302 emphasize that associations between genetic variation and gene expression in diverse tissue-and cell-types contribute to the observed differences in susceptibility and COVID-19 disease severity between individuals and indicate that genetic 304 variation likely plays an important role in determining the systemic effects of COVID-19 disease. 305 306 Although colocalization is a powerful tool to characterize the associations between GWAS and eQTL signals and to fine 307 map, it is limited by the fact that it assumes one single causal variant underlying both genetic signals per region. In 308 regions with multiple independent signals, this approach likely results in an underestimation of the colocalization between 309 GWAS and eQTLs. Therefore, our results do not exclude that multiple GWAS signals with independent molecular 310 underpinnings maybe present in some of the 11 fine mapped loci. 311 Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon 524 request. 525

526 This is a computational study that only used publicly available data. Therefore it does not include any experimental 527 models. 528

We downloaded the summary statistics on GRCh37 coordinates of 16 meta-analyses from the COVID-19 HGI data freeze 531 5 (January 18, 2021, https://www.covid19hg.org/). These studies include four phenotypes: 1) A2 = Very severe 532 respiratory confirmed COVID-19 vs. population; 2) B1 = Hospitalized vs. non-hospitalized COVID-19 patients; 3) B2 = 533

Hospitalized COVID-19 patients vs. population; and 4) C2 = COVID-19 patients vs. population. For each phenotype, four 534 meta-analyses were performed, including two on individuals from European descent and two on multiple ethnicities. All 535 the studies from three phenotypes (A2, B2 and C2) include more than 1 million controls, whereas one (B1), which tested 536 hospitalized and non-hospitalized patients, included < 6,000 cases and < 16,000 controls. 537

For each study, we identified all variants with p-value < 10 -7 (considered to have a "suggestive association with COVID-538 19") from the filtered meta-analysis summary statistics (p < 1 x 10 -5 ) provided by the COVID-19 HGI 539 (https://www.covid19hg.org/results/r5/) and expanded each variant's position by 500 kb upstream and downstream. We 540 used bedtools merge (Quinlan, 2014) to identify 23 genome-wide-significant unique loci. 541

To annotate a locus as associated with ethnicity, we required at least two studies on the same ethnicity to have p-value < 1 542

x 10 -7 . 543 eQTL data 544

We downloaded all SNP-gene association tests (including non-significant test) in all GTEx V.7 tissues and gene-level 545 information from the GTEx Portal (https://www.gtexportal.org/home/datasets). We also obtained eQTL data from 21 546 blood-related tissues from the eQTL Catalogue (https://www.ebi.ac.uk/eqtl/). The genomic coordinates from the eQTL 547

Catalogue were converted from hg38 to hg19 using liftOver. 548

In each tissue, we extracted the eQTL information for 692 genes that overlapped the 23 COVID-19 genome-wide 549 significant loci. 550

For each gene in the 23 COVID-19 genome-wide significant loci, we performed colocalization between its eQTL signal in 552 each of 48 GTEx tissues and 21 blood-related tissue and each of the 16 COVID-19 meta-analyses. We used the coloc.abf 553 function from the coloc package in R (Giambartolomei et al., 2014) to compare the p-values between each pair of SNPs 554 genotyped in both datasets. To determine the total number of individuals genotyped in each meta-analysis, we used the 555 "all_meta_sample_N" column in each summary statistics file. We used default priors: p1 (prior probability that a SNP is 556 associated with the eQTL) = 1 x 10 -4 ; p2 (prior probability that a SNP is associated with the GWAS trait) = 1 x 10 -4 ; and 557 p12 (prior probability that a SNP is associated with both GWAS trait and eQTL) = 1 x 10 -5 . We considered as each pair of 558 signals "colocalized" if their PP-H4 was greater than 0.9. At the 11 loci that colocalized with eQTLs, we selected the 559 colocalization with highest PPA and used it for fine mapping. Genetic fine mapping was performed using the coloc.abf 560 function and extracting the PPA of each SNP tested in both COVID-19 and eQTL. We defined 99% credible sets by 561 selecting the variants that contribute to 99% of the cumulative PPA. 562

To obtain LD information for each of the most likely causal variants in the colocalization between GWAS and eQTLs 564 (Figure 4) , we used LDlinkR (Myers et al., 2020) . We obtained a token from https://ldlink.nci.nih.gov/?tab=apiaccess and 565 interrogated the 1000 Genomes LD structure using the LDmatrix and LDproxy functions. 566

All LD information provided in the text and figures was generated using LDlinkR.

For each study, we identified all variants with p-value < 10 -7 (considered to have a "suggestive association with COVID-569 19") from the meta-analysis summary statistics provided by the COVID-19 HGI (https://www.covid19hg.org/results/r5/). 570

To conduct colocalization we expanded each variant's position by 500 kb upstream and downstream. 571

We considered an eQTL as colocalizing with a GWAS signal if their colocalization PPA was greater than 0.9. 572

REAGENT or RESOURCE SOURCE IDENTIFIER Deposited data COVID-19 GWAS summary statistics (Initiative, 2021) https://www.covid19hg.org/ GTEx V.7 eQTL summary statistics (Consortium, 2020) https://www.gtexportal.org/home/datasets Table S1 : Genome-wide-significant COVID-19 loci, related to Figure 1 . 576 Table S2 : Colocalization between GWAS signals and eQTLs in 62 tissues at each of the 23 genome-wide significant loci, 577 related to Figure 3 . 578 Table S3 : Fine mapped loci using eQTL information, related to Figure 4 . 579 Table S4 : Posterior probabilities of association at each of the 11 fine mapped loci, related to 

Participation of the IL-10RB Related Cytokines

IFN-lambda in Defense of the Airway Mucosal Barrier

Shared genetic effects on 587 chromatin and gene expression indicate a role for enhancer priming in immune response

Phenotypic Refinement of 591

Heart Failure in a National Biobank Facilitates Genetic Discovery

The Allelic Landscape of Human Blood 594

Cell Trait Variation and Links to Common Complex Disease

Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank

Association of an extended haplotype in the tau gene with 600 progressive supranuclear palsy

OAS-RNase L innate immune pathway mediates the 603 cytotoxicity of a DNA-demethylating drug

Reduced prevalence of 606 SARS-CoV-2 infection in ABO blood group O

Genetic association analyses 609 implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of 610 systemic lupus erythematosus

Genetic Drivers of Epigenetic and Transcriptional Variation 624 in Human Immune Cells

A genome-wide association study identifies two new risk loci for 627

The GTEx Consortium atlas of genetic regulatory effects across 629 human tissues

Epidemiology, clinical course, 632 and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort 633 study

Large-Scale Profiling Reveals the Influence of 636

Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells

Human IFNAR2 deficiency: 640 Lessons for antiviral immunity

Global BioID-based SARS-CoV-2 proteins proximal 644 interactome unveils novel ties between viral polypeptides and host factors involved in multiple 645 COVID19-associated mechanisms

Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus 648 disease

TYK2 inhibition and its potential in the treatment 651 of chronic inflammatory immune diseases

Common genetic variants 666 identify targets for COVID-19 and individuals at high risk of severe disease

Declined serum high density lipoprotein 668 cholesterol is associated with the severity of COVID-19 infection

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The COVID-19 Host Genetics Initiative, a global initiative to 674 elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus 675 pandemic

Mapping the human genetic architecture of COVID-19

MHC class II proteins and 678 disease: a structural perspective

The mutational constraint 681 spectrum quantified from variation in 141,456 humans

eQTL Catalogue: a compendium 684 of uniformly processed human gene expression and splicing QTLs. bioRxiv

A new chromosome 17q21.31 688 microdeletion syndrome associated with a common inversion polymorphism

Strong impact of natural-selection-free heterogeneity in genetics of 692 age-related phenotypes

Transcriptome and 695 genome sequencing uncovers functional variation in humans

ABO blood group associations with markers of 698 endothelial dysfunction in the Multi-Ethnic Study of Atherosclerosis

Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility 702

Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy

Racial and Ethnic Disparities in COVID-19-Related 706

Infections, Hospitalizations, and Deaths : A Systematic Review

Fine-mapping type 2 diabetes 709 loci to single-variant resolution using high-density imputation and islet-specific epigenome 710 maps

Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane 713 domain in lipid bilayers

Genome-wide association 716 study of subclinical interstitial lung disease in MESA

A genome-wide association study identifies 719 protein quantitative trait loci (pQTLs)

Viral infections in humans and mice with genetic 721 deficiencies of the type I IFN response pathway

Protein-tyrosine phosphatase sigma is 724 associated with ulcerative colitis

The H1c haplotype at the MAPT locus is 727 associated with Alzheimer's disease

LDlinkR: An R Package for Rapidly 729

Calculating Linkage Disequilibrium Statistics in Diverse Populations

Genetic Ancestry and Natural Selection Drive 732

Population Differences in Immune Responses to Pathogens

Genetic regulation 734 of the expression of ABH and Lewis antigens in tissues

Genetic mechanisms of critical 737 illness in COVID-19

A SARS-CoV-2 -host proximity interactome

SARS-CoV-2: a storm is raging

Genetic Adaptation and Neandertal Admixture 745 Shaped the Immune System of Human Populations

BEDTools: The Swiss-Army Tool for Genome Feature Analysis

Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With 751 COVID-19 in the New York City Area

The ins and outs of MHC class II-mediated antigen 753 processing and presentation

Genetic landscape of chronic 756 obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

Genome-wide association study identified new 760 susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular 761 carcinoma

COVID-19 genetic risk variants are 764 associated with expression of multiple genes in diverse immune cell types

Impact of Genetic 767 Polymorphisms on Human Immune Cell Gene Expression

Genomewide Association 770 Study of Severe Covid-19 with Respiratory Failure

Interleukin-10 receptor signaling in 773 innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage 774 function

Linkage disequilibrium and association of MAPT H1 in 777 Parkinson disease

Heterozygous variants that 780 disturb the transcriptional repressor activity of FOXP4 cause a developmental disorder with 781 speech/language delays and multiple congenital abnormalities

Genetic variants 783 modulate gene expression statin response in human lymphoblastoid cell lines

The Structure of the Membrane Protein of SARS-CoV-2 Resembles the 786 Sugar Transporter SemiSWEET

Eliciting priors and relaxing the single causal variant assumption in 788 colocalisation analyses

Low high-density lipoprotein level is correlated with the severity of COVID-19 791 patients: an observational study

Role 793 of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal 794 degeneration, and related disorders

Hypolipidemia is associated with the severity of COVID-19

Genome-wide association study of medication-use and associated 801 disease in the UK Biobank

Impacts a Network of Inflammatory and DNA Damage Response Genes in the Pancreatic beta-804

FOXP4 modulates 806 tumor growth and independently associates with miR-138 in non-small cell lung cancer cells

A map of transcriptional 810 heterogeneity and regulatory variation in human microglia

A genomic region associated with protection against severe 812 COVID-19 is inherited from Neandertals

Genome-wide association study identifies new loci associated with risk of HBV 815 infection and disease progression

Assessment of Molecular Subtypes in Thyrotoxic Periodic 818 Paralysis and Graves Disease Among Chinese Han Adults: A Population-Based Genome

Association Study

Clinical course and risk factors for mortality of adult inpatients with

China: a retrospective cohort study